Quantitative Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Quantitative Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-18,700	Closed	-$1.57M	–	621
2018 Q2	$1.57M	Sell	18,700 -1,300	-7%	-$113K	0.03%	409
2018 Q1	$1.64M	Buy	20,000 +16,400	+456%	+$1.27M	0.03%	495
2017 Q4	$205K	Sell	3,600 -163,000	-98%	-$10.3M	﹤0.01%	720
2017 Q3	$11.1M	Buy	166,600 +120,100	+258%	+$7.21M	0.13%	209
2017 Q2	$2.39M	Sell	46,500 -24,600	-35%	-$1.26M	0.04%	468
2017 Q1	$4.15M	Buy	+71,100	New	+$3.41M	0.06%	365
2016 Q4	–	Sell	-41,300	Closed	-$2.18M	–	765
2016 Q3	$2.18M	Buy	+41,300	New	+$1.8M	0.07%	297
2016 Q2	–	Sell	-10,200	Closed	-$414K	–	721
2016 Q1	$414K	Buy	+10,200	New	+$436K	0.02%	578

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Quantitative Investment Management's AGIO Position: Q3 2018 in Review

Quantitative Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2018, closing a stake of 18,700 shares — an estimated $1.57M sold.

Quantitative Investment Management first reported a position in AGIO in Q1 2016 and held it in 8 quarters. The position peaked at $11.1M in Q3 2017. 208 funds tracked by Wall St. Rank hold AGIO as of Q3 2018.

Quantitative Investment Management reported no remaining Agios Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Quantitative Investment Management sold 18,700 Agios Pharmaceuticals shares in Q3 2018, an estimated $1.57M.
Quantitative Investment Management first reported a position in Agios Pharmaceuticals in Q1 2016 and held it in 8 quarters.
Quantitative Investment Management's Agios Pharmaceuticals position peaked at $11.1M in Q3 2017.
208 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2018.

Based on Quantitative Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.